Viome Life Sciences, a genomic testing company, has raised $67 million in a series C funding round. The round was led by Bold Capital Group alongside existing investors Khosla Ventures, WestRiver ...
BELLEVUE, Wash.--(BUSINESS WIRE)--Today, Viome, a longevity company committed to translating scientific advancements into practical and individualized health solutions, has announced the introduction ...
Viome's Full Body Intelligence Test ™ is the only science backed at-home test that decodes your body's biological signals to give you precision health insights. It reveals not just what's happening ...
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Kurt Schlosser on Jul 17, 2024 at ...
First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps — early warning signs of colorectal cancer — before they become cancerous. Study aims to ...
Viome Life Sciences has launched Oral Health Pro with CancerDetect that can detect oral and throat cancer. The test, which is available now, measures gene expression of the oral microbiome and human ...
Healthcare company Viome has released an at-home RNA-based saliva test that identifies underlying causes of oral health conditions, including bad breath and gum inflammation. Viome uses the test ...
Study aims to enhance colorectal cancer prevention by identifying polyp molecular signals, offering improved sensitivity over at-home DNA tests, which have limited ability to detect precancerous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback